Young Plasma Induces Antidepressant-Like Effects in Aged Rats Subjected to Chronic Mild Stress by Suppressing Indoleamine 2,3-Dioxygenase Enzyme and Kynurenine Pathway in the Prefrontal Cortex

• Published in: Neurochemical research 2022-02, Vol.47 (2), p.358-371
• Main Authors: Ghaffari-Nasab, Arshad, Badalzadeh, Reza, Mohaddes, Gisou, Javani, Gonja, Ebrahimi-kalan, Abbas, Alipour, Mohammad Reza
• Format: Article
• Language: English
• Subjects: Aging; Aging (artificial); Animals; Antidepressants; Antidepressive Agents - pharmacology; Antidepressive Agents - therapeutic use; Biochemistry; Biomedical and Life Sciences; Biomedicine; Brain; Cell Biology; Depression - metabolism; Disease Models, Animal; Hippocampus - metabolism; Indoleamine-Pyrrole 2,3,-Dioxygenase - metabolism; Interferon; Kynurenine - metabolism; Male; Mental depression; Metabolites; Neurochemistry; Neurology; Neurosciences; Original Paper; Plasma; Prefrontal cortex; Prefrontal Cortex - metabolism; Protein transport; Rats; Rodents; Serotonin; Serotonin transporter; Stress, Psychological - metabolism; Sucrose; Tryptophan; Tryptophan 2,3-dioxygenase; γ-Interferon
• ISSN: 0364-3190; 1573-6903
• DOI: 10.1007/s11064-021-03440-9

Pathophysiology of depression in elderlies is linked to aging-associated increase in indoleamine 2,3-dioxygenase (IDO) levels and activity and kynurenine (Kyn) metabolites. Moreover, these aging-induced changes may alter the brain’s responses to stress. Growing evidence suggested that young plasma can positively affect brain dysfunctions in old age. The present study aimed to investigate whether the antidepressant effects of young plasma administration in aged rats subjected to chronic unpredictable mild stress (CUMS) and underlying mechanisms, focusing on the prefrontal cortex (PFC). Young (3 months old) and aged (22 months old) male rats were divided into five groups; young control, aged control, aged rats subjected to CUMS (A + CUMS), aged rats subjected to CUMS and treated with young plasma (A + CUMS + YP), and aged rats subjected to CUMS and treated with old plasma (A + CUMS + OP). Plasma was injected (1 ml, intravenously) three times per week for four weeks. Young plasma significantly improved CUMS-induced depressive-like behaviors, evidenced by the increased sucrose consumption ratio in the sucrose preference test and the reduced immobility time in the forced swimming test. Furthermore, young plasma markedly reduced the levels of interferon-gamma (IFN-γ), IDO, Kyn, and Kyn to tryptophan (Kyn/Trp) ratio in PFC tissue. Expression levels of the serotonin transporter and growth-associated protein (GAP)-43 were also significantly increased after chronic administration of young plasma. These findings provide evidence for the antidepressant effect of young plasma in old age; however, whether it improves depressive behaviors or faster recovery from stress-induced deficits is required to be elucidated.